Recombinant Human IL-1 alpha GMP Protein _ 90271ES

YeasenSKU: 90271ES10

Size: 10 μg
Preis:
Verkaufspreis$165.00
Aktie:
Auf Lager

Interleukin-1 alpha (IL-1α) is a non-secreted pro-inflammatory cytokine produced by a variety of cells, including monocytes, tissue macrophages, keratinocytes, and other epithelial cells. It exerts metabolic, physiological, and hematopoietic activities, and plays a central role in the regulation of immune responses. IL-1α is encoded by the IL1A gene and signals through two receptors, IL-1RI and IL-1RII, both of which are shared with IL-1β; the two cytokines therefore exhibit similar biological properties. These cytokines display a broad range of activities, including induction of B cell maturation and proliferation and promotion of fibroblast proliferation and type I procollagen synthesis.

Product Properties

Item

Specification

Synonyms

Interleukin-1 alpha, IL-1α, BAF, IL-1F1, LAF, LEM, preinterleukin 1 alpha, pro-interleukin-1-alpha

Species

Human

Expressed Sequence

Ser 113 - Ala 271

Accession

P01583

Tag

No Tag

Expression System

E. coli

Molecular Weight

Approximately 17.5 kDa.

Purity

> 95% as determined by SDS-PAGE and HPLC.

Endotoxin

< 0.01 EU per μg by the LAL method.

Formulation

0.22 μm filtered concentrated solution in PBS.

Appearance

Lyophilized Powder

Biological Activity

The ED50 as determined by the dose-dependent stimulation of murine D10S cells is ≤ 10 pg/mL.

Reconstitution Method

It is recommended to reconstitute the protein in sterile PBS to a concentration of 0.1-1.0 mg/mL. Avoid repeated freeze-thaw cycles whenever possible.

Features

High purity: >95%, preventing immune reactions caused by residual host cell protein (HCP) or DNA.

Ultra-low endotoxin: <10 EU/mg, minimizing the risk of fever or inflammation.

Batch-to-batch consistency: ensuring stability and reproducibility in cell culture.

Regulatory compliance: meeting regulatory requirements for cell therapy products and supporting IND submissions.

Animal-origin-free: free of animal viruses, pathogenic agents, and adventitious agent contamination, ensuring high safety.

Regulatory Guideline Compliance

The manufacturing and quality control of GMP-grade proteins comply with the following systems and processes:

1. Complies with the General Principles of Volume III of the Pharmacopoeia of the People's Republic of China (2020 Edition): Quality Control of Raw Materials and Excipients for Biological Product Manufacturing.

2. Complies with USP Chapter <92> Growth Factors and Cytokines Used in Cell Therapy Manufacturing.

3. Complies with Ph. Eur. General Chapter 5.2.12, Raw Materials of Biological Origin for the Production of Cell-based and Gene Therapy Medicinal Products.

Quality Management System

1. GMP proteins are manufactured, tested, and released under an ISO 13485:2016-certified quality management system, ensuring batch-to-batch consistency and material traceability.

2. Supplied with an approved Certificate of Analysis (COA).

3. Animal-origin-free materials and production environment.

4. Manufacturing site for pharmaceutical raw materials and excipients.

5. On-site and remote audits supported.

Product Safety Testing System

Endotoxin: <10 EU/mg

Residual host DNA: < 20 ng/mg

Residual host cell protein: < 0.5 ng/μg

Sterility test: Negative

Mycoplasma test: Negative

Adventitious virus test: Negative

Figures

SDS-PAGE

Figure 1. Human IL-1 alpha GMP Protein on SDS-PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC

Figure 2. The purity of Human IL-1 alpha GMP Protein is greater than 95% as determined by SEC-HPLC.

Cell Based Assay

Figure 3. The ED50 as determined by the dose-dependent stimulation of murine D10S cells is ≤ 10 pg/mL.

Storage

Store at -25 to -15°C, valid for 3 years. After reconstitution, store at -85 to -65°C, valid for 3 months.

FAQ

Citations

Documents

Applications

Sie können auch mögen

Anfrage

FAQ

Das Produkt ist nur für Forschungszwecke bestimmt und nicht für die therapeutische oder diagnostische Anwendung bei Menschen oder Tieren. Produkte und Inhalte sind durch Patente, Marken und Urheberrechte von Yeasen Biotechnology geschützt. Markensymbole geben das Herkunftsland an, nicht unbedingt die Registrierung in allen Regionen.

Für bestimmte Anwendungen sind möglicherweise zusätzliche geistige Eigentumsrechte Dritter erforderlich.

Yeasen engagiert sich für ethische Wissenschaften und ist davon überzeugt, dass unsere Forschung kritische Fragen ansprechen und gleichzeitig Sicherheit und ethische Standards gewährleisten sollte.